People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Immunic, Inc. | — | Biotechnology | Series D+ | $514.4M | $1.3B | 2009 |
| Optiscan Biomedical Corp | — | Other Health Care | Series B | $131.6M | $443.1M | 2012 |
| PolyRemedy Inc | — | Other Health Care | Series A | $13.7M | $10.9M | 2009 |
| Southern Implants, Inc. | — | Other Health Care | Seed | $5.0M | $49.6M | 2009 |
Charles Liamos at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Liamos on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Annette Campbell-White | 2 | 11 |
| Michael Greeley | 1 | 15 |
| Patrick Walsh | 1 | 9 |
| Hoyoung Huh | 1 | 7 |
| Stephen Shapiro | 1 | 6 |
| Dennis Condon | 1 | 5 |
| Paul Mieyal | 1 | 5 |
| Douglas Roeder | 1 | 5 |
| Jeffrey Jones | 1 | 5 |
| Kevin Barrett | 1 | 5 |
| Kevin Connors | 1 | 4 |
| Cary . Vance | 1 | 4 |
| Lowell E. Sears | 1 | 4 |
| Aditya Puri | 1 | 4 |
| Daniel Eckert | 1 | 3 |
| Rod Dammeyer | 1 | 3 |
| KENNETH ABRAMOWITZ | 1 | 3 |
| Muneer A. Satter | 1 | 3 |
| Graham Blackbeard | 1 | 3 |
| Peter Rule | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.